Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway

Cardiovascular Research

Volumn 84, Issue 1, 2009, Pages 54-63

  Zhou, Yang ^a   Bourcy, Katherine ^a   Kang, Y James ^a,b  

^a University of Louisville School of Medicine   (United States)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Cardiomyocyte; Copper; Hypertrophy; PKG 1; VEGF; VEGFR

Indexed keywords

COPPER; COPPER SULFATE; CYCLIC GMP DEPENDENT PROTEIN KINASE; PHENYLEPHRINE; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; CGMP DEPENDENT PROTEIN KINASE IALPHA; CGMP-DEPENDENT PROTEIN KINASE IALPHA;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CARDIOMYOCYTE HYPERTROPHY; CELL GROWTH; CELL HYPERPLASIA; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE SILENCING; HEART MUSCLE CELL; HYPOTHESIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; CARDIOMEGALY; CELL CULTURE; CHEMISTRY; DRUG EFFECT; GENETICS; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CARDIOMEGALY; CELLS, CULTURED; COPPER; CYCLIC GMP-DEPENDENT PROTEIN KINASES; MYOCYTES, CARDIAC; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 70449717085     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp178     Document Type: Article

References (22)

1. Zhou Y, Jiang Y, Kang YJ. Copper reverses cardiomyocyte hypertrophy through vascular endothelial growth factor-mediated reduction in the cell size. J Mol Cell Cardiol 2008;45:106-117.
2. Jiang Y, Reynolds C, Xiao C, Feng W, Zhou Z, Rodriguez W et al. Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice. J Exp Med 2007;204:657-666.
3. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao RL et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 2005;115:2108-2118.
4. Walsh K, Shiojima I. Cardiac growth and angiogenesis coordinated by intertissue interactions. J Clin Invest 2007;117:3176-3179.
5. Ruch C, Skiniotis G, Steinmetz MO, Walz T, Ballmer-Hofer K. Structure of a VEGF-VEGF receptor complex determined by electron microscopy. Nat Struct Mol Biol 2007;14:249-250.
6. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 1995;10:135-147.
7. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 1994;269: 26988-26995.
8. Reynolds AR, Reynolds LE, Nagel TE, Lively JC, Robinson SD, Hicklin DJ et al. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice. Cancer Res 2004;64:8643-8650.
9. ClarkDE, SmithSK,HeY,DayKA,Licence DR, CorpsANetal.Avascular endo-thelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 1998;59:1540-1548.
10. Zeng H, Dvorak HF, Mukhopadhyay D. Vascular permeability factor (VPF)/ vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. J Biol Chem 2001;276:26969-26979.
11. Rahimi N, Dayanir V, Lashkari K. Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mito-genic activity of VEGFR-2 in endothelial cells. J Biol Chem 2000;275: 16986-16992.
12. Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D et al. Role of PlGF in the intra-and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 2003;9:936-943.
13. Kroll J, Waltenberger J. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J Biol Chem 1997;272:32521-32527.
14. Takahashi N, Seko Y, Noiri E, Tobe K, Kadowaki T, Sabe H et al. Vascular endothelial growth factor induces activation and subcellular transloca-tion of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes. Circ Res 1999;84:1194-1202. (Pubitemid 29244781)
15. Shimojo N, Jesmin S, Zaedi S, Otsuki T, Maeda S, Yamaguchi N et al. Contributory role of VEGF overexpression in endothelin-1-induced cardio-myocyte hypertrophy. Am J Physiol Heart Circ Physiol 2007;293: H474-H481.
16. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y et al. P53-induced inhibition of HIF-1 causes cardiac dysfunction during pressure overload. Nature 2007;446:444-448.
17. Shyu KG, Liou JY, Wang BW, Fang WJ, Chang H. Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1a and vascular endothelial growth factor in pressure-overloaded rat heart. J Biomed Sci 2005;12:409-420. (Pubitemid 40897646)
18. Izumiya Y, Shiojima I, Sato K, Sawyer DB, Colucci WS, Walsh K. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 2006;47:887-893.
19. Fiedler B, Lohmann SM, Smolenski A, Linnemuller S, Pieske B, Schroder F et al. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Proc Natl Acad Sci USA 2002;99:11363-11368.
20. Wollert KC, Fiedler B, Gambaryan S, Smolenski A, Heineke J, Butt E et al. Gene transfer of cGMP-dependent protein kinase I enhances the antihy-pertrophic effects of nitric oxide in cardiomyocytes. Hypertension 2002;39:87-92.
21. Takimoto E, Champion HC, Li M, Belardi D, Ren S, Rodriguez ER et al. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med 2005;11:214-222.
22. Trumbo P, Yates AA, Schlicker S, Poos M. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc 2001;101:294-301.